Olema Pharmaceuticals, Inc. (OLMA)
13.67
-0.45
(-3.19%)
USD |
NASDAQ |
Mar 27, 16:00
13.67
0.00 (0.00%)
After-Hours: 17:07
Olema Pharmaceuticals Cash from Investing (Quarterly) : -162.18M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -322.77M |
| EyePoint Plc | -74.67M |
| CytomX Therapeutics, Inc. | -14.42M |
| Corvus Pharmaceuticals, Inc. | 10.88M |
| Protagonist Therapeutics, Inc. | 48.82M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -38.33M |
| Cash from Financing (Quarterly) | 213.55M |
| Free Cash Flow | -146.72M |
| Free Cash Flow Per Share (Quarterly) | -0.4197 |
| Free Cash Flow to Equity (Quarterly) | -38.04M |
| Free Cash Flow to Firm (Quarterly) | -38.33M |
| Free Cash Flow Yield | -12.34% |